RACHAEL JOHNSON: Open Payments
NPI 1245421536 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 14 payments from 8 companies in 2025. Trend: 2023 $316 · 2024 $436 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $42 |
| Astellas Pharma US Inc | 2 | $33 |
| Biogen, Inc. | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Exeltis, USA Inc. | 1 | $23 |
| CooperSurgical, Inc. | 1 | $23 |
Products named: GEMTESA, IMBRUVICA, Veozah, ZURZUVAE, NOVASURE, SLYND, Paragard T 380A, EPKINLY.
Industry payments across IN — which companies pay providers there.
